Pyruvate kinase
Assets acting on this target.
- Class
- Pyruvate kinase activator
Related mechanisms
Pyruvate kinase drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| MitapivatPyrukynd | AGIOS PHARMACEUTICALS, INC., Avanzanite Bioscience | small molecule | Approved | Approved in Pyruvate Kinase Deficiency; Phase 3 in Sickle Cell Disease; Phase 3 in Transfusion-Dependent Beta Thalassemia |
| Mitapivat (Aqvesme)Aqvesme | AGIOS PHARMACEUTICALS, INC. | small molecule | Approved | Approved in Transfusion-Dependent Beta Thalassemia |
| Etavopivat | Novo Nordisk | Not recorded | Phase 3 | Phase 3 in Sickle Cell Disease |